de AllianceBernstein Acadia Pharmaceuticals ACAD Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 3.59 M | Comprar |
161,066
+11,739
| +8% | +USD 258 k | ﹤0.01% | 1736 |
|
|
2026
Q1 | USD 3.99 M | Vender |
149,327
-6,916
| -4% | -USD 165 k | ﹤0.01% | 1648 |
|
|
2025
Q4 | USD 4.17 M | Comprar |
156,243
+1,250
| +0.8% | +USD 29.9 k | ﹤0.01% | 1626 |
|
|
2025
Q3 | USD 3.31 M | Vender |
154,993
-57
| -0% | -USD 1.35 k | ﹤0.01% | 1724 |
|
|
2025
Q2 | USD 3.34 M | Comprar |
155,050
+9,770
| +7% | +USD 182 k | ﹤0.01% | 1673 |
|
|
2025
Q1 | USD 2.41 M | Vender |
145,280
-2,200
| -1% | -USD 40 k | ﹤0.01% | 1797 |
|
|
2024
Q4 | USD 2.71 M | Mantener |
147,480
| – | – | ﹤0.01% | 1804 |
|
|
2024
Q3 | USD 2.27 M | Mantener |
147,480
| – | – | ﹤0.01% | 1896 |
|
|
2024
Q2 | USD 2.4 M | Vender |
147,480
-401
| -0.3% | -USD 6.47 k | ﹤0.01% | 1843 |
|
|
2024
Q1 | USD 2.73 M | Comprar |
147,881
+17,100
| +13% | +USD 424 k | ﹤0.01% | 1749 |
|
|
2023
Q4 | USD 4.09 M | Vender |
130,781
-520
| -0.4% | -USD 12.4 k | ﹤0.01% | 1578 |
|
|
2023
Q3 | USD 2.74 M | Vender |
131,301
-60,810
| -32% | -USD 1.65 M | ﹤0.01% | 1707 |
|
|
2023
Q2 | USD 4.6 M | Comprar |
192,111
+39,910
| +26% | +USD 887 k | ﹤0.01% | 1459 |
|
|
2023
Q1 | USD 2.86 M | Vender |
152,201
-50,000
| -25% | -USD 952 k | ﹤0.01% | 1678 |
|
|
2022
Q4 | USD 3.22 M | Comprar |
202,201
+50,000
| +33% | +USD 782 k | ﹤0.01% | 1637 |
|
|
2022
Q3 | USD 2.49 M | Vender |
152,201
-17,300
| -10% | -USD 280 k | ﹤0.01% | 1741 |
|
|
2022
Q2 | USD 2.39 M | Comprar |
169,501
+15,900
| +10% | +USD 297 k | ﹤0.01% | 1838 |
|
|
2022
Q1 | USD 3.72 M | Vender |
153,601
-49,649
| -24% | -USD 1.2 M | ﹤0.01% | 1730 |
|
|
2021
Q4 | USD 4.74 M | Vender |
203,250
-73,800
| -27% | -USD 1.48 M | ﹤0.01% | 1650 |
|
|
2021
Q3 | USD 4.6 M | Comprar |
277,050
+122,660
| +79% | +USD 2.36 M | ﹤0.01% | 1651 |
|
|
2021
Q2 | USD 3.77 M | Comprar |
154,390
+69,561
| +82% | +USD 1.57 M | ﹤0.01% | 1793 |
|
|
2021
Q1 | USD 2.19 M | Vender |
84,829
-27,369
| -24% | -USD 1.2 M | ﹤0.01% | 2045 |
|
|
2020
Q4 | USD 6 M | Comprar |
112,198
+33,299
| +42% | +USD 1.65 M | ﹤0.01% | 1389 |
|
|
2020
Q3 | USD 3.26 M | Vender |
78,899
-12,871
| -14% | -USD 556 k | ﹤0.01% | 1582 |
|
|
2020
Q2 | USD 4.45 M | Vender |
91,770
-149,999
| -62% | -USD 7.2 M | ﹤0.01% | 1387 |
|
|
2020
Q1 | USD 10.2 M | Vender |
241,769
-3,300
| -1% | -USD 136 k | 0.01% | 904 |
|
|
2019
Q4 | USD 10.5 M | Comprar |
245,069
+30,580
| +14% | +USD 1.33 M | 0.01% | 1069 |
|
|
2019
Q3 | USD 7.72 M | Comprar |
214,489
+50,790
| +31% | +USD 1.54 M | ﹤0.01% | 1155 |
|
|
2019
Q2 | USD 4.38 M | Comprar |
163,699
+9,700
| +6% | +USD 248 k | ﹤0.01% | 1503 |
|
|
2019
Q1 | USD 4.14 M | Vender |
153,999
-69,741
| -31% | -USD 1.63 M | ﹤0.01% | 1480 |
|
|
2018
Q4 | USD 3.62 M | Comprar |
223,740
+77,400
| +53% | +USD 1.5 M | ﹤0.01% | 1479 |
|
|
2018
Q3 | USD 3.04 M | Mantener |
146,340
| – | – | ﹤0.01% | 1641 |
|
|
2018
Q2 | USD 2.24 M | Comprar |
146,340
+45,744
| +45% | +USD 816 k | ﹤0.01% | 1832 |
|
|
2018
Q1 | USD 2.26 M | Comprar |
100,596
+2,309
| +2% | +USD 63.9 k | ﹤0.01% | 1747 |
|
|
2017
Q4 | USD 2.96 M | Vender |
98,287
-150
| -0.2% | -USD 4.8 k | ﹤0.01% | 1578 |
|
|
2017
Q3 | USD 3.71 M | Vender |
98,437
-58
| -0.1% | -USD 1.89 k | ﹤0.01% | 1403 |
|
|
2017
Q2 | USD 2.75 M | Vender |
98,495
-30,312
| -24% | -USD 903 k | ﹤0.01% | 1612 |
|
|
2017
Q1 | USD 4.43 M | Vender |
128,807
-120
| -0.1% | -USD 4.24 k | ﹤0.01% | 1258 |
|
|
2016
Q4 | USD 3.72 M | Vender |
128,927
-443
| -0.3% | -USD 11.7 k | ﹤0.01% | 1383 |
|
|
2016
Q3 | USD 4.12 M | Vender |
129,370
-4,900
| -4% | -USD 166 k | ﹤0.01% | 1231 |
|
|
2016
Q2 | USD 4.36 M | Vender |
134,270
-50,290
| -27% | -USD 1.68 M | ﹤0.01% | 1141 |
|
|
2016
Q1 | USD 5.16 M | Vender |
184,560
-1,356,372
| -88% | -USD 29.6 M | ﹤0.01% | 1046 |
|
|
2015
Q4 | USD 54.9 M | Comprar |
1,540,932
+128,954
| +9% | +USD 4.54 M | 0.05% | 427 |
|
|
2015
Q3 | USD 46.7 M | Comprar |
1,411,978
+1,261,578
| +839% | +USD 52.5 M | 0.04% | 449 |
|
|
2015
Q2 | USD 6.3 M | Mantener |
150,400
| – | – | 0.01% | 1024 |
|
|
2015
Q1 | USD 4.9 M | Comprar |
150,400
+400
| +0.3% | +USD 13.7 k | ﹤0.01% | 1133 |
|
|
2014
Q4 | USD 4.76 M | Vender |
150,000
-3,400
| -2% | -USD 96.4 k | ﹤0.01% | 1146 |
|
|
2014
Q3 | USD 3.8 M | Mantener |
153,400
| – | – | ﹤0.01% | 1235 |
|
|
2014
Q2 | USD 3.46 M | Vender |
153,400
-69
| -0% | -USD 1.44 k | ﹤0.01% | 1361 |
|
|
2014
Q1 | USD 3.73 M | Comprar |
153,469
+5,753
| +4% | +USD 146 k | ﹤0.01% | 1295 |
|
|
2013
Q4 | USD 3.69 M | Vender |
147,716
-6
| -0% | -USD 142 | ﹤0.01% | 1297 |
|
|
2013
Q3 | USD 4.06 M | Comprar |
147,722
+13,601
| +10% | +USD 284 k | ﹤0.01% | 1186 |
|
|
2013
Q2 | USD 2.43 M | Comprar |
+134,121
| Nuevas | +USD 1.85 M | ﹤0.01% | 1464 |
|
Otros fondos que tienen ACAD en su cartera
BBA
Posición de AllianceBernstein en ACAD: resumen de T2 2026
AllianceBernstein aumentó su participación en Acadia Pharmaceuticals (ACAD) en 7.9% durante T2 2026, al comprar aproximadamente USD 258 k y elevar la posición a 161,066 acciones con un valor de USD 3.59 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1736.
AllianceBernstein reportó por primera vez una posición en ACAD en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 54.9 M en T4 2015. Al cierre de T2 2026, 354 fondos que sigue Wall St. Rank mantienen una posición en ACAD.
- Al cierre de T2 2026, AllianceBernstein tenía 161,066 acciones de Acadia Pharmaceuticals con un valor de USD 3.59 M.
- AllianceBernstein compró 11,739 acciones de Acadia Pharmaceuticals en T2 2026, por un monto estimado de USD 258 k.
- Acadia Pharmaceuticals representó ﹤0.01% de la cartera de AllianceBernstein en T2 2026 y fue su posición número 1736.
- AllianceBernstein reportó por primera vez una posición en Acadia Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de AllianceBernstein en Acadia Pharmaceuticals alcanzó su máximo de USD 54.9 M en T4 2015.
- Al cierre de T2 2026, 354 fondos que sigue Wall St. Rank tenían Acadia Pharmaceuticals en cartera.
Según el Informe 13F de AllianceBernstein correspondiente a T2 2026, presentado el 14 ago 2026.